InfinixBio New York stands out as a leading Contract Research Organization (CRO), dedicated to facilitating drug development and biopharmaceutical innovations across various sectors. Our expertise in preclinical research and drug discovery allows us to support biotech and pharmaceutical companies through every stage of their development lifecycle.
At InfinixBio New York, we pride ourselves on delivering full-service capabilities tailored to meet the unique demands of our clients. Here’s a closer look at our key offerings:
Our assay development services include a range of specialized techniques designed to yield reliable and reproducible results. Whether it’s conducting bioanalytical method validation or protein biochemistry, our experienced scientists employ the latest methodologies to ensure success.
InfinixBio New York excels in moving projects from target identification to hit-to-lead development. We meticulously handle each step of the drug discovery process, ensuring that our clients have the vital support they need to advance their candidates.
Our comprehensive immunogenicity testing services are crucial for biopharmaceutical developers. Understanding potential immune responses is essential for both therapeutic efficacy and safety. We specialize in anti-drug antibody (ADA) analysis and gene therapy immunogenicity that positions clients for success.
Through rigorous pharmacokinetic (PK) analysis, we provide insights into the absorption and distribution of drug candidates. Our IND-enabling studies help our clients navigate regulatory requirements and prepare effectively for clinical trials.
While InfinixBio does not manage clinical data or provide regulatory oversights, we do offer consultancy services to navigate the complex regulatory landscapes. By ensuring compliance with FDA and EMA standards, we enable our clients to focus on their core innovations, while we manage the intricacies of regulatory submissions.
Partnering with InfinixBio New York translates into numerous benefits for biotech and pharmaceutical companies:
At InfinixBio New York, we possess extensive knowledge across a variety of therapeutic areas, including oncology, neuroscience, rare diseases, immunology, and more. This diverse expertise allows us to adapt to evolving industry demands and extend our services efficiently.
What types of clients does InfinixBio New York serve?
We cater primarily to biotech and pharmaceutical companies, as well as academic institutions involved in drug development.
How can InfinixBio facilitate my project?
Our extensive range of preclinical services allows you to accelerate drug development efficiently. We work closely with you to customize an approach that meets your specific project goals.
What makes InfinixBio different from other CROs?
Our commitment to scientific excellence, coupled with our tailored client services, sets us apart. We genuinely partner with our clients to navigate the challenges of drug development.
InfinixBio New York is dedicated to supporting the modern biopharmaceutical landscape through a complete suite of CRO services. Our innovative, client-focused approach provides the expertise and resources necessary to turn scientific visions into reality. To learn more about how we can partner with you, contact us today.
Our experienced lab team is here to help. Reach out today to learn more.
Back to Glossary